Bender Robert & Associates
- SEC CIK
- 0000894300
- Latest filing
- Jul 30, 2026
CLVS holding history
Clovis Oncology, Inc. in every 13F filed by Bender Robert & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CLVS overviewAll 13F holders of CLVSFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −50,000−100.0% | Sold out | Holders |
| Q3 2022 | 50,000 | $60.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 50,000 | $90.0K | <0.1% | +50,000 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −50,000−100.0% | Sold out | Holders |
| Q1 2021 | 50,000 | $351.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.